Agency Information Collection Activities: Proposed Collection; Comment Request, 58267 [2018-25142]
Download as PDF
<![CDATA[
58267
Federal Register / Vol. 83, No. 223 / Monday, November 19, 2018 / Notices
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel; H3Africa Biorepository.
Date: December 14, 2018.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NHGRI, Greider Conference Room
3321, 6700B Rockledge Dr., Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852, (301) 402–0838,
pozzattr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: November 13, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–25108 Filed 11–16–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and, (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: 2019 National Survey
on Drug Use and Health (OMB No.
0930–0110)—Extension
Agency Information Collection
Activities: Proposed Collection;
Comment Request
The data are used to determine the
prevalence of use of tobacco products,
alcohol, illicit substances, and illicit use
of prescription drugs. The results are
used by SAMHSA, the Office of
National Drug Control Policy (ONDCP),
federal government agencies, and other
organizations and researchers to
establish policy, to direct program
activities, and to better allocate
resources.
This is an extension to the 2019
National Survey on Drug Use and
Health (NSDUH). There are no
substantive changes to the questionnaire
or changes in burden. The 2019 NSDUH
will continue to include questions on
medication-assisted treatment (MAT)
and kratom.
As with all NSDUH surveys
conducted since 1999, including those
prior to 2002 when the NSDUH was
referred to as the National Household
Survey on Drug Abuse, the sample size
of the survey for 2019 will be sufficient
to permit prevalence estimates for each
of the 50 states and the District of
Columbia. The total annual burden
estimate is shown below in Table 1.
The National Survey on Drug Use and
Health (NSDUH) is a survey of the U.S.
civilian, non-institutionalized
population aged 12 years old or older.
In compliance with section
3506(c)(2)(A) of the Paperwork
TABLE 1—ANNUALIZED ESTIMATED BURDEN FOR 2019 NSDUH
Number of
respondents
Instrument
Total number
of responses
Hours per
response
Total burden
hours
Household Screening ...........................................................
Interview ...............................................................................
Screening Verification ..........................................................
Interview Verification ............................................................
137,231
67,507
4,116
10,126
1
1
1
1
137,231
67,507
4,116
10,126
0.083
1.000
0.067
0.067
11,390
67,507
276
678
Total ..............................................................................
137,231
........................
218,980
........................
79,851
Send comments to Summer King,
SAMHSA Reports Clearance Officer,
Room 15E57B, 5600 Fishers Lane,
Rockville, MD 20857 or email a copy to
summer.king@samhsa.hhs.gov.
Written comments should be received
by January 18, 2019.
Summer King,
Statistician.
khammond on DSK30JT082PROD with NOTICES
Responses
per
respondent
[FR Doc. 2018–25142 Filed 11–16–18; 8:45 am]
BILLING CODE 4162–20–P
VerDate Sep<11>2014
17:20 Nov 16, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention’s
(CSAP) Drug Testing Advisory Board
(DTAB) will convene via in person and
web conference on December 4, 2018,
from 9:00 a.m. EST to 3:30 p.m. EST and
December 5, 2018, from 9:00 a.m. EST
to 4:00 p.m.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
The Board will meet in open-session
in-person on December 4, 2018, from
9:00 a.m. EST to 3:30 p.m. EST to
discuss the proposed Mandatory
Guidelines for Federal Workplace Drug
Testing Programs (urine specimens)
with updates from the Department of
Transportation, Nuclear Regulatory
Commission, and the Department of
Defense. There will be additional
presentations from the Division of
Workplace Programs’ staff on urine, oral
fluid, hair Mandatory Guidelines and
future direction, updates on electronic
chain of custody and standard variables,
and emerging issues surrounding
marijuana legalization. The board will
meet in closed-session in-person on
E:\FR\FM\19NON1.SGM
19NON1
]]>Agencies
[Federal Register Volume 83, Number 223 (Monday, November 19, 2018)]
[Notices]
[Page 58267]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-25142]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Proposed Collection;
Comment Request
In compliance with section 3506(c)(2)(A) of the Paperwork Reduction
Act of 1995 concerning opportunity for public comment on proposed
collections of information, the Substance Abuse and Mental Health
Services Administration (SAMHSA) will publish periodic summaries of
proposed projects. To request more information on the proposed projects
or to obtain a copy of the information collection plans, call the
SAMHSA Reports Clearance Officer on (240) 276-1243.
Comments are invited on: (a) Whether the proposed collections of
information are necessary for the proper performance of the functions
of the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and, (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
Proposed Project: 2019 National Survey on Drug Use and Health (OMB No.
0930-0110)--Extension
The National Survey on Drug Use and Health (NSDUH) is a survey of
the U.S. civilian, non-institutionalized population aged 12 years old
or older. The data are used to determine the prevalence of use of
tobacco products, alcohol, illicit substances, and illicit use of
prescription drugs. The results are used by SAMHSA, the Office of
National Drug Control Policy (ONDCP), federal government agencies, and
other organizations and researchers to establish policy, to direct
program activities, and to better allocate resources.
This is an extension to the 2019 National Survey on Drug Use and
Health (NSDUH). There are no substantive changes to the questionnaire
or changes in burden. The 2019 NSDUH will continue to include questions
on medication-assisted treatment (MAT) and kratom.
As with all NSDUH surveys conducted since 1999, including those
prior to 2002 when the NSDUH was referred to as the National Household
Survey on Drug Abuse, the sample size of the survey for 2019 will be
sufficient to permit prevalence estimates for each of the 50 states and
the District of Columbia. The total annual burden estimate is shown
below in Table 1.
Table 1--Annualized Estimated Burden for 2019 NSDUH
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total number Hours per Total burden
Instrument respondents respondent of responses response hours
----------------------------------------------------------------------------------------------------------------
Household Screening............. 137,231 1 137,231 0.083 11,390
Interview....................... 67,507 1 67,507 1.000 67,507
Screening Verification.......... 4,116 1 4,116 0.067 276
Interview Verification.......... 10,126 1 10,126 0.067 678
-------------------------------------------------------------------------------
Total....................... 137,231 .............. 218,980 .............. 79,851
----------------------------------------------------------------------------------------------------------------
Send comments to Summer King, SAMHSA Reports Clearance Officer,
Room 15E57B, 5600 Fishers Lane, Rockville, MD 20857 or email a copy to
[email protected].
Written comments should be received by January 18, 2019.
Summer King,
Statistician.
[FR Doc. 2018-25142 Filed 11-16-18; 8:45 am]
BILLING CODE 4162-20-P
